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Abstract
Mycobacteria are intracellular pathogens that have macrophages as their main host cells. 
However, macrophages are also the primary line of defence against invading microorgan-
isms. To survive in the intracellular compartment, virulent mycobacteria have developed 
several strategies to modulate the activation and the effector functions of macrophages. 
Despite this, antigen-specific T cells develop during infection. While T-cell responses are 
critical for protection they can also contribute to the success of mycobacteria as human 
pathogens, as immunopathology associated with these responses facilitates transmission. 
Here, we provide a brief overview of different immune-evasion strategies of mycobacteria 
and their impact on the protective immune response. This understanding will further our 
knowledge in host–pathogen interactions and may provide critical insights for the develop-
ment of novel host-specific therapies.
Introduction
Mycobacteria are one of the most important and well-adapted group of human pathogens. 
Among diseases caused by mycobacteria, tuberculosis, caused by Mycobacterium tubercu-
losis, is undeniably one of the oldest recorded human diseases, and still one of the biggest 
killers. While mortality has decreased significantly since the 1990s (WHO, 2015), in 2014 
alone, 9.6 million people were estimated to fall ill with tuberculosis and 1.5 million died 
from the disease (WHO, 2015). After tuberculosis, leprosy and Buruli ulcer, caused by 
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Mycobacterium leprae and Mycobacterium ulcerans, respectively, are the second and third 
most common mycobacterial diseases in humans (Walsh et al., 2010). Although leprosy was 
declared eliminated in the end of 2000 in most countries by the World Health Organization 
(WHO), incidence remains fairly stable, suggesting active transmission (Schreuder et al., 
2016; Walsh et al., 2010). On the other hand, Buruli ulcer is a re-emerging disease mainly 
due to environmental factors including deforestation, artificial topographic alterations 
(such dams and irrigation systems), and increasing populations engaged in basic manual 
agriculture in wetlands (Merritt et al., 2010; van Ravensway et al., 2012).
The outcome of mycobacterial infections depends upon their interaction with the host 
immune system. These interactions can result in control of infection, establishment of latent 
infection or development of disease (Casanova and Abel, 2002). Specifically for M. tuber-
culosis, genetic analyses suggest that this pathogen and humans coevolved for thousands of 
years (Comas et al., 2013). During this time, M. tuberculosis has developed multiple and 
redundant strategies to manipulate macrophage activation and establish an intracellular 
niche to prevent elimination. Despite this, antigen-specific T cells are activated upon expo-
sure to mycobacteria, and these cells are an essential component of the protective response 
(Cooper, 2009). However, the inflammatory environment generated during infection can 
have important consequences for T-cells function and control of infection. In some cases 
this environment may even promote T-cell-mediated immunopathology, which facilitates 
transmission of infection. Therefore, immune evasion by mycobacteria is a rather sophisti-
cated process, wherein the highly adapted pathogen uses multiple and redundant strategies 
to manipulate the host response and establish a suitable environment for proliferation, while 
promoting the immune-mediated damage required for transmission.
Here, we discuss some of the strategies used by mycobacteria to evade the host immune 
system and how these strategies impact the protective response.
Mycobacteria use redundant strategies to inhibit the 
microbicidal activity of myeloid cells
Upon infection, resident macrophages and dendritic cells (DCs) are likely to be the first 
cells to interact with mycobacteria. Owing the success of mycobacteria as pathogens, it is 
not surprising that some of the most important adaptations that pathogenic mycobacte-
ria have acquired throughout evolution are directed at modulating the activation and the 
effector functions of these cells. For example, one of the first mycobacterial virulence traits 
identified and studied in detail, was the ability of M. tuberculosis to inhibit the fusion of 
the mycobacteria-containing phagosomes with acidified lysosomes (Armstrong and Hart, 
1971). A process similar to phagosome–lysosome fusion is autophagy. Autophagy is 
controlled by autophagy-related genes (Atg) and relies on the formation of an autophago-
some which engulfs components of the cytoplasm and delivers them to degradation in the 
lysosome (Mizushima et al., 2011). It is now well established that M. tuberculosis can also 
interfere with autophagy (Romagnoli et al., 2012; Shin et al., 2010). Although phagocytosis 
and autophagy are independent processes, both phagosomes and autophagosomes mature 
through acidification and acquisition of proteolytic enzymes that degrade intracellular 
material, including mycobacteria. These processes are not only important to control intra-
cellular pathogen growth, but also affect acquired immune responses. Indeed, proteins and 
peptides degraded in the phagolysosome or autophagolysosome can then be loaded in major 
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histocompatibility complex (MHC) molecules thereby inducing T-cell activation (Vyas et 
al., 2008). Here we discuss some of the mechanisms wherein mycobacteria interfere with 
phagosome–lysosome fusion and autophagy to prevent rapid elimination and establish an 
intracellular niche to thrive.
The highly characteristic cell wall (Brennan and Nikaido, 1995) and capsular layer (Sani 
et al., 2010) of mycobacteria is composed of unique glycolipids, glucans and proteins that 
engage several host pathogen recognition receptors (PRRs) thereby shaping the response 
of myeloid cells in the infection site (Awuh and Flo, 2016). Phagocytosis of M. tuberculosis 
has been shown to be mediated through multiple receptors expressed by macrophages, such 
as Fcγ receptors, complement receptor type 3 and lectin receptors (Schäfer et al., 2009). 
Fcγ receptors and complement receptor type 3 promote phagocytosis of the bacteria coated 
with IgG antibodies and complement protein fragment C3bi, respectively (Caron and Hall, 
1998).
During primary infection, phagocytosis of M. tuberculosis appears to be mostly through 
non-opsonic mechanisms (Schäfer et al., 2009). This occurs likely because serum and com-
plement components are limited in the alveolar space when the first interaction between 
M. tuberculosis and macrophages occurs (Schäfer et al., 2009; Schluger, 2001). On the other 
hand, opsonized uptake of M. tuberculosis may be more important at later stages of the infec-
tion (Schäfer et al., 2009). The relevance of these mechanisms is highlighted by the fact 
that phagocytosis of opsonized mycobacteria does not appear to inhibit phagosome–lyso-
some fusion (Kang et al., 2005) whereas phagocytosis of non-opsonized mycobacteria does 
(Hmama et al., 2015; Kang et al., 2005). For example, phagocytosis of mycobacteria through 
mannose receptor (MR) binding of the mannose-capped lipoarabinomannan (ManLAM), 
one of the most prominent molecular patterns found in the cell wall of pathogenic myco-
bacteria (Brennan and Nikaido, 1995), results in phagosome–lysosome fusion arrest (Kang 
et al., 2005). Interestingly, however, ManLAM has also been shown to interact with other 
PRRs, namely the dendritic cell-specific intracellular adhesion molecule 3 grabbing nonin-
tegrin (DC-SIGN) and, more recently, Dectin-2 expressed by DCs (Yonekawa et al., 2014). 
While the engagement of ManLAM with Dectin-2, in what regard phagosome–lysosome 
fusion, has not been yet determined, engagement of ManLAM with DC-SIGN does not 
induce phagosome–lysosome arrest (Kang et al., 2005).
The effect of ManLAM on phagocytic cells is however not limited to phagosome-
lysosome arrest but it also stimulates the production of cytokines, co-stimulatory molecules 
and MHC-II expression, important for macrophage function and stimulation of acquired 
responses (Kallenius et al., 2016). Indeed, stimulation of bone marrow-derived DCs with 
ManLAM induces the production of IL-10, IL-12p40, IL-6 and TNF-α, up-regulation of 
the co-stimulatory molecules CD80 and CD86 and MHC-II, in a Dectin-2-dependent 
manner (Yonekawa et al., 2014). Importantly, mice deficient in Dectin-2 are more suscep-
tible to disease after M. avium pulmonary infection, showing that recognition of ManLAM 
by Dectin-2 is important to control infection (Yonekawa et al., 2014). On the other hand, a 
recent study compared the virulence M. tuberculosis and M. bovis BCG with isogenic strains 
lacking the CapA locus, which is involved in the biosynthesis of the mannose cap of LAM 
(Afonso-Barroso et al., 2013). This study showed that mycobacteria lacking the mannose 
cap of LAM were not less virulent than the isogenic strains that have ManLAM (Afonso-
Barroso et al., 2013). Thus, taken together, these data suggest that during infection the 
effects of ManLAM may be redundant and in the absence of this molecular pattern other 
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ligands are engaged by the same receptors in myeloid cells. In this regard, several molecular 
patterns have been identified to interact with DC-SIGN (Appelmelk et al., 2008; Driessen 
et al., 2009; Geijtenbeek et al., 2003; Pitarque et al., 2005). An example is α-glucan that has 
been shown to induce the production of IL-10 upon lipopolysaccharide (LPS) stimulation 
of DCs, without altering IL-12p40 production (Geurtsen et al., 2009). In the context of 
the whole bacteria however, it has been shown that stimulation of monocyte-derived DCs 
with M. bovis BCG, grown in conditions that are permissive to the maintenance of the cap-
sular layer (rich in α-glucan), produced significantly lower levels of IL-12 and TNF-α, when 
compared to M. bovis BCG that did not have the α-glucan-rich capsular layer (Sani et al., 
2010). A recent study identified PPE10 protein, secreted by Esx-5, as the main responsible 
for maintaining the mycobacterial capsular integrity (Ates et al., 2016). Interestingly, M. 
marinum deficient in Esx-5 or PPE10 were less virulent that the complemented strains in 
zebrafish embryos (Ates et al., 2016), highlighting the importance of the capsular layer, and 
α-glucan, in the immune response and control of infection.
The above described data highlight the complex interaction between mycobacteria and 
phagocytic cells during infection. Specifically for ManLAM, its recognition through MR 
results in phagosome-lysosome arrest (Kang et al., 2005), but its recognition through other 
PRRs may result in a different response leading to the production of cytokines, including 
TNF-α, IL-6, IL-12, IL-10 (Kallenius et al., 2016) that have multiple roles during infec-
tion (Domingo-Gonzalez et al., 2016; Torrado and Cooper, 2013). When these data are 
taken together with other data showing that (i) several mycobacterial molecular patterns 
are recognized by host cells through multiple PRRs, including Toll-like receptors (TLR), 
NOD-like receptors, Dectin-1 and Mincle; and (ii) engagement of these receptors leads to 
the production cytokines important in macrophage function and in the infection process 
(Awuh and Flo, 2016; Killick et al., 2013; Mortaz et al., 2015; Rajaram et al., 2014); it is 
plausible to conclude that most of the molecular patterns of mycobacteria have redundant 
effects on phagocytic cells (Killick et al., 2013). Because of these redundant functions, in 
some cases absence of one receptor in the host, or one molecular pattern in the pathogen, 
does not translate in altered bacterial burdens or pathology to the host. The data described 
above for ManLAM are an example. On the host side, absence of TLR-2 or TLR-9 does not 
impact the ability of mice to control M. tuberculosis infection; however, mice deficient in 
both TLR-2 and TLR-9 revealed to be more susceptible to M. tuberculosis infection (Bafica 
et al., 2005).
Together, these data suggest not only that there is some degree of redundancy in the 
effects of mycobacterial molecular patterns, but also that the targeting of specific PRRs is 
critical for the pathogen to establish an intracellular niche and survive in the infected host.
In addition to molecular patterns recognized by cell-surface receptors during phagocy-
tosis, M. tuberculosis has also been shown to secrete effector molecules that interfere with 
intracellular vesicle trafficking. Two of the most well characterized effectors that interfere 
with phagosome–lysosome fusion are PtpA (Bach et al., 2008) and SapM (Vergne et al., 
2005). The mechanisms by which these proteins interfere with phagosome–lysosome 
fusion have been recently reviewed (Hmama et al., 2015).
Other important mycobacterial proteins that trigger phagosome-lysosome arrest 
include TB10.4 (encoded by esxH) and TB9.8 (encoded by esxG), which are secreted 
by the mycobacterial Esx-3 type VII secretion system (Mehra et al., 2013). The TB10.4/
TB9.8 heterodimer is able to interact with the hepatocyte growth factor-regulated tyrosine 
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kinase substrate (Hgs/Hrs), a component of the Endosomal Sorting Complex Required 
for Transport (ESCRT) (Mehra et al., 2013). The ESCRT transport system is composed 
by four protein complexes that are sequentially recruited to the endosomal membrane, 
promoting the delivery of phagocytosed mycobacteria to the lysosome, thus restricting 
intracellular bacterial growth (Mehra et al., 2013). The heterodimer was shown to directly 
target Hrs, inhibiting delivery of bacteria to lysosomes (Mehra et al., 2013). It is worth 
noting that TB10.4/TB9.8 are highly antigenic, and a high frequency of T cells specific for 
these antigens has been shown to correlate with protection against M. tuberculosis infection 
(Hervas-Stubbs et al., 2006). In fact, the introduction of the M. tuberculosis Esx-3 locus into 
an M. smegmatis strain lacking the endogenous Esx-3 region generates highly protective 
immunity against M. tuberculosis (Sweeney et al., 2011). There is also a role for Esx-3 of M. 
tuberculosis and M. smegmatis in iron and zinc acquisition (Serafini et al., 2009; Siegrist et al., 
2014).
The Esx-1 type VII secretion system also secretes other highly antigenic T-cell proteins 
that interfere with intracellular vesicle trafficking, such as the early secretory antigen target 
6 kDa (ESAT-6, encoded by esxA) and the culture filtrate antigen 10 kDa (CFP-10, encode 
by esxB) (Tan et al., 2006). However, a more important biological role of these proteins 
in mycobacterial pathogenesis is their phagosomal permeabilization properties implicated 
in rupture and translocation of M. tuberculosis and M. leprae from the phagosome into the 
cytosol (van der Wel et al., 2007), activation of autophagy (Watson et al., 2012) as well as 
the inflammasome (Mishra et al., 2013). The importance of these proteins in infection is 
highlighted by several studies showing that, mutations affecting the synthesis or secretion 
of ESAT-6/CFP10 attenuate the virulence of mycobacteria in murine models of infection 
(Hsu et al., 2003; Lewis et al., 2003; Pym et al., 2002, 2003).
Together, these data show that mycobacteria use redundant mechanisms to prevent mac-
rophage activation and functions, highlighting the importance of these strategies to prevent 
rapid elimination.
Initial studies on macrophages infected with M. tuberculosis or M. bovis BCG suggested 
that autophagy induction could overcome phagososme–lysosome arrest imposed by myco-
bacteria (Gutierrez et al., 2004). This and following studies, established autophagy as an 
important antimycobacterial defence mechanism, not only by overcoming phagosome-
lysosome arrest, but also by promoting the generation of antimicrobial peptides with 
activity against mycobacteria (Ponpuak et al., 2010). The critical role of autophagy during 
M. tuberculosis infection is underlined by the acute susceptibility of mice conditionally defi-
cient for Atg5 in phagocytic cells (Castillo et al., 2012; Kimmey et al., 2015; Watson et al., 
2012), a phenotype similar to that of IFN-γ-deficient mice (Cooper et al., 1993; Flynn et 
al., 1993; Nandi and Behar, 2011). However, more recent data showed that deficiency in 
other Atg genes important for autophagy did not impact control of M. tuberculosis infection 
(Kimmey et al., 2015), suggesting that Atg5 participates in unique functions not provided 
by other essential Atg proteins. Indeed, Atg5 deficiency in alveolar macrophages or DCs did 
not significantly impact control of infection; as opposed to Atg5 deficiency in neutrophils, 
which resulted in uncontrolled recruitment of these cells to the infection site (Kimmey et al., 
2015). The role of neutrophils in the susceptibility of Atg5 deficient mice was determined 
by antibody depletion studies that reverted the acute susceptible phenotype of Atg5 defi-
cient mice (Kimmey et al., 2015).
Although the data discussed above suggest autophagy-independent roles of Atg5 in 
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controlling resistance to M. tuberculosis infection, several factors produced by M. tuberculosis 
have been identified to interfere with the autophagic process. The ε-aminoacetyltransferase 
Eis, for instance, has been shown to acetylate Lys-55 in a JNK-specific phosphatase and is 
critical to activate the autophagy regulator Beclin 1 (Kim et al., 2012). Similar to phagos-
some–lysosome fusion, the Esx-1 secretion system has also been implicated in inhibiting 
autophagy in human DCs (Romagnoli et al., 2012). Likewise, the PE_PGRS47 protein has 
been recently shown to inhibit autophagy with impact on antigen presentation, but without 
affecting MHC-II expression (Saini et al., 2016). This protein was identified in a screening of 
random genomic DNA fragments of M. tuberculosis capable of inhibiting antigen processing 
and loading into MHC-II (Saini et al., 2016). Compared to the wild-type or PE_PGRS47 
complemented strains, macrophages infected with the mutant PE_PGRS47 strain showed 
an increase in microtubule-associated light chain 3 (LC3), a central component of 
autophagosome formation, and p62, which is recruited to newly formed autophagosomes 
(Saini et al., 2016). These findings thus suggest that PE_PGRS47 prevents the formation 
of autophagosomes containing intracellular M. tuberculosis. Moreover, in vivo experiments 
show that mice infected with the PE_PGRS47 mutant strain of M. tuberculosis were more 
resistant to infection, maintaining lower bacterial burdens throughout chronic infection 
when compared to mice infected with the wild-type or complemented strains (Saini et al., 
2016). Interestingly, while there were no differences in the frequency of antigen-specific 
CD4 T cells at day 9 post infection (when T cells are primed in the lymph nodes, discussed 
below), there were more antigen-specific CD4 T cells at day 24 post infection in mice 
infected with the M. tuberculosis strain deficient in PE_PGRS47 than in mice infected with 
the wild-type or complemented strains (Saini et al., 2016). These data show that by inter-
fering with intracellular vesicle trafficking, M. tuberculosis impairs antigen-processing and 
subsequent loading into MHC-II molecules.
Since there were no differences in the frequency of CD4 T cell at day 9 post infection 
(Saini et al., 2016), the data discussed above also suggest that inhibition of autophagy may 
not impact T-cell priming. In this regard, several studies have shown that mycobacteria 
can modulate antigen presentation through different mechanisms, including inhibition of 
MHC-II expression or antigen-processing and loading (Hmama et al., 2015). However, 
these mechanisms may not fully explain the delayed T-cell priming during mycobacterial 
infection (discussed below) but may rather be more important for T-cell function in the 
infection site. A recent study took advantage of MHC-II mixed bone-marrow chimeras to 
compare the bacterial burdens in myeloid cells that were capable (MHC-II-expressing), 
or not (MHC-II deficient), of interacting with CD4 T cells (Srivastava and Ernst, 2013). 
Results showed that myeloid cells expressing MHC-II had reduced bacterial burdens when 
compared to myeloid cells that did not express MHC-II (Srivastava and Ernst, 2013). 
Therefore, direct recognition of infected cells by CD4 T cells appears to be required for con-
trolling intracellular M. tuberculosis in the infection site. Accordingly, depletion of CD4 T 
cells resulted in increased numbers of bacteria in MHC-II-expressing myeloid cells but not 
MHC-II deficient cells (Srivastava and Ernst, 2013). These data suggest that, by interfering 
with autophagy and phagosome–lysosome fusion, M. tuberculosis may prevent the interac-
tion between infected macrophages and antigen-specific CD4 T cells at the infection site, 
thereby limiting the ability of CD4 T cells to activate M. tuberculosis-infected macrophages.
Collectively, these studies show that during the first interaction with myeloid cells in 
the infection site different mycobacterial molecular patterns are recognized by distinct host 
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receptors, resulting in signals leading to phagosome-lysosome arrest, but also the produc-
tion of pro- and anti-inflammatory cytokines and chemokines with important roles during 
infection (Domingo-Gonzalez et al., 2016; Torrado and Cooper, 2013). The different and 
redundant strategies used by mycobacteria to inhibit phagosome–lysosome fusion and 
autophagy highlight the key role of these strategies in the early establishment of an intracel-
lular niche for the pathogen to proliferate (Fig. 7.1). During the course of infection, the 
balance between these signals may play key roles in determining the early control of infec-
tion and induction of T-cell responses (Fig. 7.1).
Mycobacteria modulate the microenvironment to subvert 
infected-cell death pathways and recruit permissive 
macrophages
Although mycobacteria are well equipped to prevent and escape phagosome–lysosome 
fusion and autophagy, macrophages can still activate apoptotic cell death programmes 
Figure 7.1 Progression of the immune response to M. tuberculosis infection. Early interaction 
with phagocytes through PRRs results in the phagocytosis of the bacteria. Virulent M. 
tuberculosis interferes with intracellular vesicle trafficking and escapes the phagosome to 
prevent early elimination and establish an intracellular niche. At the same macrophages, and 
other inflammatory cells in the site of infection, produce inflammatory mediators that can impact 
the cell death modality of the infected-cell and induce the recruitment of other inflammatory 
cells. High levels of IFN-αβ induce the recruitment of CCR2-expressing monocytes with limited 
ability to control bacterial growth. As infected cells dies newly recruited macrophages and 
monocytes efferocytose or phagocytose the bacteria and a granulomatous reaction begins 
to form. After the onset of acquired immunity, T cells begin to accumulate and a granuloma is 
formed. The efficient interaction between T cells and macrophages together with a balanced 
production of cytokines and chemokines results in a non-damaging inflammatory environment 
and control of infection. On the other hand, phagocytosis of the bacteria by permissive 
macrophages with a weak capacity to interact with T cells results in progression of infection. As 
the granuloma coalesces, the inflammatory environment generated may promote the constant 
accumulation of T cells contributing to immunopathological consequences to the host.
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to prevent further microbial intracellular replication and increase exposure of microbial 
antigens. Apoptosis is a tightly regulated process of cellular deconstruction that minimizes 
inflammation and pathology by containing the dismembered cellular contents of dying 
cells within membrane-bound vesicles, called apoptotic bodies (Taylor et al., 2008). These 
apoptotic bodies emit signals to be engulfed and digested by phagocytes in a process called 
efferocytosis (Martin et al., 2014). On the other hand, necrosis is a more inflammatory 
process when compared to apoptosis, as it is defined by loss of membrane integrity with 
the release of intracellular contents to the extracellular space (Moraco and Kornfeld, 2014).
A growing body of evidence points to the ability of M. tuberculosis to inhibit apoptotic 
and promote necrotic cell death of macrophages as an important determinant of virulence 
and pathogenesis (Behar et al., 2010; Chen et al., 2008; Chen et al., 2006; Divangahi et al., 
2009; Divangahi et al., 2010). Early studies suggested apoptosis, but not necrosis, of the 
mycobacterial-infected cells to have direct bactericidal effects on intracellular bacterial via-
bility. However, more recent data suggest that apoptosis itself is not intrinsically bactericidal 
but instead requires efferocytosis (Martin et al., 2012).
One key mechanism wherein virulent M. tuberculosis prevents apoptosis and promotes 
necrotic death of infected macrophages is by regulating eicosanoid production (Chen et al., 
2008). Mechanistically, avirulent M. tuberculosis H37ra strain has been shown to stimulate 
the production of prostaglandin E2 (PGE2), which is required for plasma membrane protec-
tion by regulating synaptotagmin 7, the calcium sensor involved in the lysosome-mediated 
repair mechanism (Divangahi et al., 2009). On the other hand, virulent M. tuberculosis 
H37rv and Erdman strains stimulate the production of lipoxins, such as lipoxin A4 (LXA4), 
which in turn down-regulate cyclooxygenase (COX)2 mRNA, thereby reducing PGE2 
production and preventing its membrane protective effects, resulting in necrotic death of 
the infected cell (Chen et al., 2008; Divangahi et al., 2009). The relevance of these pathways 
is demonstrated by the observation that Alox5-deficient macrophages, which cannot syn-
thesize LXA4, undergo more apoptosis and are better able to control M. tuberculosis H37Rv 
growth when compared to wild-type macrophages. On the other hand, PGE2-deficient 
macrophages undergo more necrosis and do not to control intracellular growth of either 
virulent or avirulent M. tuberculosis (Divangahi et al., 2009). Therefore, apoptosis appears to 
be the fate of M. tuberculosis-infected cells if mitochondrial and plasma membrane integrity 
is protected by PGE2, whereas necrosis occurs if LXA4 predominates. How M. tuberculosis 
induces LXA4 production is not yet determined. Likely, the Esx-1 secretion system-induced 
rupture of the mycobacteria vacuole (van der Wel et al., 2007), as well as the pore forming 
activity of ESAT-6 (Smith et al., 2008), are important in the process. Another candidate 
is CpnT, a NAD+-glycohydrolase which depletes cellular NAD+ pools, resulting in host 
necrotic cell death (Danilchanka et al., 2014; Sun et al., 2015).
The ability of M. tuberculosis to prevent apoptosis of its host cells can also affect the 
T-cell response (Divangahi et al., 2010). Indeed, when alveolar macrophages from M. 
tuberculosis-infected wild-type or Alox5-deficient mice were transferred into wild-type 
mice, the Alox5-deficient macrophages were able to stimulate pulmonary and systemic CD4 
and CD8 T-cell responses, in contrast to wild-type macrophages (Divangahi et al., 2010). 
These enhanced T-cell responses were not directly induced by the transferred macrophages. 
Instead, the antigen cargo contained within the apoptotic vesicles of Alox5-deficient mac-
rophages was phagocytosed by DCs that, in turn, stimulated T-cell responses (Divangahi et 
al., 2010).
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The role of lipid mediators can also directly influence T-cell responses. For example, PGE2 
has been shown to directly promote the differentiation and proinflammatory functions of 
human and murine Th17 cells (Boniface et al., 2009; Gopal et al., 2012). In this regard, IL-17 
and Th17 cells are an important component of the protective immune response to highly 
virulent strains of M. tuberculosis (Gopal et al., 2014), but uncontrolled Th17 responses 
can result in important immunopathological consequences to the host (Cruz et al., 2010; 
Torrado and Cooper, 2010). More recently, IL-17 was found to promote the intracellular 
growth of Mycobacterium bovis BCG and M. tuberculosis by inhibiting the intrinsic apoptotic 
pathway (Cruz et al., 2015a). This study showed that IL-17 induces a down-regulation of 
the apoptosis master regulator p53 resulting in a reduction in the percentage of caspase-
3-positive macrophages, as well as an increase in the ratio of Bcl2/Bax proteins (Cruz et al., 
2015a). Together, these data suggest that during the early stages of infection the balance 
between eicosanoids plays a key role in determining the cell death modality of the infected 
cell; as the infection progresses the inflammatory environment generated in the infection 
site may alter this balance (Fig. 7.1). Future research is required to address these issues.
In addition to regulating the infected-cell death modality, PGE2 has been recently shown 
to regulate the production of type I interferons (IFN-α/β) (Mayer-Barber et al., 2014). IFN-
α/β has been shown to have a largely detrimental role in tuberculosis (Berry et al., 2010; 
Manca et al., 2001; Ordway et al., 2007), with more virulent strains (such as Beijing strains) 
inducing the highest production of IFN-α/β (Carmona et al., 2013; Manca et al., 2001). The 
induction of IFN-α/β is likely associated with the phagosome membrane rupture mediated 
by the Esx-1 secretion system (van der Wel et al., 2007) triggering a cytosolic DNA sensor 
and activating the Sting/Tbk1/Irf3 axis (Manzanillo et al., 2012). This pathway is also 
activated by multiple PRRs, including TLRs (Barber, 2011). In this regard, M. tuberculosis 
Beijing strains have been shown to induce IFN-α/β through a TLR-4-dependent pathway 
(Carmona et al., 2013).
The detrimental role of IFN-α/β during mycobacterial infections is complex and likely 
involves different mechanisms. One of these mechanisms is associated with the recruitment 
of permissive macrophages to the infection site. Indeed, induction of IFN-α/β production 
by intranasal challenge of M. tuberculosis-infected mice with polyinosinic-polycytidylic acid 
condensed with poly-l-lysine and carboxymethylcellulose (Poly-ICLC) results in elevated 
bacterial burdens associated with increased accumulation of a CD11b+Gr1int myeloid popu-
lation recruited via the CCL2-CCR2 pathway (Antonelli et al., 2010). In Poly-ICLC treated 
mice, CD11b+Gr1int cells displayed decreased expression of MHC-II and elevated bacterial 
levels when compared to the same subset of cells purified from infected, untreated controls 
(Antonelli et al., 2010).
In another recent paper, it was shown that both M. tuberculosis and M. marinum actively 
promote the recruitment permissive macrophages by using cell-surface-associated phthioc-
erol dimycoceroserate (PDIM) lipids through a host CCR2-mediated pathway (Cambier et 
al., 2014). Interestingly, these PDIM appear to mask underlying mycobacterial molecular 
patterns. In the absence of PDIM, these molecular patterns signal a TLR-dependent recruit-
ment of macrophages that produce nitric oxide and control intracellular M. tuberculosis 
and M. marinum growth (Cambier et al., 2014). Whether or not this CCR2 pathway is also 
activated by IFN-α/β, was not determined. This intricate immune evasion strategy also 
provides an explanation for the observation that M. tuberculosis initiates infection in the 
lower airways, a relatively sterile environment. Indeed, in the upper airways the normal flora 
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provides the TLR stimulation required to recruit microbicidal macrophages that are capable 
of controlling M. tuberculosis infection (Cambier et al., 2014).
The other detrimental role of IFN-α/β is by suppressing IFN-γ-dependent macrophage 
activation (Teles et al., 2013). This role of IFN-α/β is particularly evident in leprosy, which 
presents in two distinct clinical manifestations: a disseminated form (leprematous) or a 
self-healing form (tuberculoid). Self-healing tuberculoid lesions were shown to be associ-
ated with IFN-γ and its downstream vitamin D-dependent antimicrobial genes, whereas 
disseminated and progressive leprematous lesions were associated with an IFN-α/β gene 
programme, including IL-10 (Teles et al., 2013). Importantly, IFN-γ-induced antimicrobial 
activity against M. leprae in monocytes was abrogated by IFN-α/β or IL-10 (Teles et al., 
2013). Recently, IFN-α/β was also shown to induce IL-10 production, which in turn inhib-
its the production of TNF-α, IL-12, and IL-1β and impaired the ability of IFN-γ-activated 
macrophages to control M. tuberculosis (McNab et al., 2014). Taking into account that 
tuberculosis also consists of a spectrum of disease, even though not as distinct as leprosy, it 
is possible that IFN-α/β responses are involved in defining this spectrum.
Despite its largely detrimental role, IFN-α/β may also have protective functions during 
M. tuberculosis infection. Indeed, mice lacking both IFN-α/β and IFN-γ signalling are more 
susceptible to infection, when compared to single deficient mice (Desvignes et al., 2012; 
Moreira-Teixeira et al., 2016). In this model, the function of IFN-α/β receptor signalling 
was suggested to limit the early recruitment of permissive macrophages (Desvignes et al., 
2012). In accordance with this protective role is the observation that IFN-α/β may pro-
mote expression of the inducible Nitric Oxide Synthase (iNOS, encoded by Nos2) during 
the early stages of M. tuberculosis infection (Moreira-Teixeira et al., 2016). Therefore, low 
amounts of IFN-α/β may be protective by activating macrophages to restrict intracellular 
mycobacterial growth; however, production of too much IFN-α/β results in the recruitment 
of large numbers of permissive macrophages, preventing control of infection.
Collectively, these data show that mycobacteria modulate the inflammatory environment 
of the infection site to interfere with the cell death modality of its host cells while promoting 
the recruitment of permissive macrophages to the infection site (Fig. 7.1).
Delayed T-cells priming during mycobacterial infections
Antigen-specific T cells are an essential component of the protective response to mycobac-
teria (Cooper, 2009). During tuberculosis, T-cell effector responses are dominated by Th1 
(defined by IFN-γ production) and, to a lesser extent, Th17 (defined by IL-17 production) 
phenotypes, as well as CD8 T cells. These populations play key roles in the protective and 
pathological response (Behar, 2013; Cooper, 2009; Lin and Flynn, 2015; Torrado and 
Cooper, 2010; Torrado et al., 2011).
One of the most intriguing aspects of the host response against mycobacteria is the 
delayed priming of the T-cell response. As priming and initiation of acquired immune 
responses are difficult to address in humans, due to limitations in sampling and determining 
time of exposure, the aerosol mouse model of infection has been used to address this issue 
(Gallegos et al., 2008; Reiley et al., 2008; Wolf et al., 2008). Using this model, the bacteria 
is deposited in the lung lower airways where M. tuberculosis grows in an apparent uncon-
trolled manner, until day 21 post infection (Cooper and Khader, 2008; Khader et al., 2007). 
Notwithstanding, several studies have shown that antigen-specific T cells only become 
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activated after day 7–10 of infection and that T-cell priming occurs in the lung draining 
mediastinal lymph nodes, but not in the lung (Gallegos et al., 2008; Reiley et al., 2008; Wolf 
et al., 2008). This slow onset in the acquired response is in marked contrast to the kinetics 
typically observed for other aerogenic infections, such as influenza (Flynn et al., 1998) and 
Francisella tularensis (Baron et al., 2007), or with other intracellular bacteria, such as Listeria 
monocytogenes (Kursar et al., 2002). In these infections, T-cell priming and expression of 
T-cell immunity in the infection site occurs as early as 3–7 days post infection and results in 
a rapid control of viral or bacterial proliferation (Baron et al., 2007; Flynn et al., 1998; Kursar 
et al., 2002).
The slow pace at which the T-cell response is initiated could be, at least partially, 
explained by the reduced antigen production, associated with the slow proliferation rate 
of M. tuberculosis. However, during in vitro growth M. tuberculosis rapidly secretes T-cell 
antigenic proteins to the culture medium (Andersen et al., 1992; Andersen et al., 1991). 
Therefore, if the slow mycobacterial growth accounted for insufficient antigen for CD4 
T-cell activation, the time required to initiate the immune response should be reduced by 
increasing the dose of infection. However, increasing the dose of infection by a factor of 10 
does not significantly enhance T-cell priming (Reiley et al., 2008; Wolf et al., 2008). On 
the other hand, the observations that (i) T-cell priming in the draining mediastinal lymph 
node after aerosol challenge coincides with the arrival of viable bacteria to this location 
(Reiley et al., 2008; Wolf et al., 2008); and that (ii) the delay in the control of M. tuberculosis 
infection in the lungs after aerosol infection contrasts with the immediate control in the 
liver upon intravenous challenge, despite the fact that in both cases control of infection was 
associated with the accumulation of IFN-γ-producing CD4 T cells (Cooper, 2009; Cooper 
et al., 1997a); suggest that dissemination of the bacteria to the draining lymph node is likely 
essential to T-cell priming. This hypothesis is also consistent with the observations that the 
lung environment is not optimal for T-cell priming, as myeloid cells isolated from lungs of 
M. tuberculosis-infected mice induce poor T-cell cytokine responses, when compared to the 
same populations isolated from the lymph nodes (Wolf et al., 2007). Therefore to initiate 
T-cell responses, M. tuberculosis-infected myeloid cells need to migrate to the lymph node.
Still the question remains on why these cells do not migrate quicker to the draining 
lymph nodes. While there is still no definitive answer to this question, as referred above 
it is known that increasing the infection dose does not significantly enhance this response 
(Reiley et al., 2008; Wolf et al., 2008). As such, the bacteria itself does not appear to inhibit 
the migration of the infected cells; instead, primary infected cells are likely non-migratory 
cells. Therefore, despite the ability of M. tuberculosis to interfere with myeloid cell mecha-
nisms required for T-cell activation, such as MHC-II expression (Hmama et al., 2015), the 
delay in T-cell priming is largely attributed to the microenvironment of the lung and the 
transport of M. tuberculosis, or its antigens, to the draining lymph nodes.
In this regard, the transport of M. tuberculosis from the lung to the draining lymph nodes 
has been recently shown to be made by Ly6C monocytes, in a CCR2-dependent way (Sam-
stein et al., 2013). It is interesting to note, however, that these cells are not lung resident 
but migrate from the bone-marrow to the infection site in response to CCR2-binding 
chemokines, CCL2 and CCL7, where they presumably differentiate into macrophages or 
DCs (Serbina and Pamer, 2006). How these cells uptake M. tuberculosis, or its antigens, is 
still not known. The function of Ly6C monocytes in T-cell priming appears to be limited 
to shuttling the bacteria, or its antigens, to the draining lymph nodes as they do not prime 
UNCORRECTED PROOF Date: 16:21 Tuesday 25 April 2017
File: Bacterial Evasion 1P (AB)
Fraga et al.178 |
T cells directly (Samstein et al., 2013). Perhaps this is the result of M. tuberculosis’ ability 
to interfere with the differentiation of monocytes. Indeed, it has been suggested that M. 
tuberculosis infection impairs the differentiation of monocytes into DCs, inducing instead, 
the generation of macrophage-like cells that fail to up-regulate co-stimulatory and MHC-II 
molecules (Remoli et al., 2011).
As T-cell priming is delayed, one could speculate that if primed T cells that were already 
in the lung and ready to respond, control of infection would be more efficient. Indeed, mice 
infected with M. tuberculosis and subsequently treated with antibiotics to generate memory-
immune mice (Cooper et al., 1997a) or vaccinated with BCG (Cruz et al., 2015b) control 
M. tuberculosis faster than naive mice; however, the kinetics of the protective response is still 
slow and control of infection is only observed at day 14 post infection (Cooper et al., 1997a; 
Cruz et al., 2015b). One possible caveat of these experiments is that the memory T-cell 
response generated by live bacteria does not populate the lung. To overcome this, transgenic 
CD4 T cells primed in vitro in Th1 differentiating conditions (to promote the development 
of IFN-γ-producing T cell) were transferred into naive mice before aerosol M. tuberculosis 
infection (Gallegos et al., 2008). These transferred effector cells were shown to populate the 
lung and produce IFN-γ and, as expected, provided enhanced protection (Gallegos et al., 
2008); however, this enhanced protection was only detected after day 7 of infection (Gal-
legos et al., 2008). Thus, delayed T-cell priming is not the only issue in preventing the rapid 
control of infection, but the ability of the effector T cells to sense antigen in the lung is also 
critical (Srivastava and Ernst, 2013). The establishment of an intracellular niche, described 
above, is therefore important for M. tuberculosis to shelter for the T-cell response.
The impact of the inflammatory environment in accumulating T 
cells
As T cells accumulate in the infected organ, bacterial proliferation is controlled (Cooper and 
Khader, 2008; Khader et al., 2007; Winslow et al., 2003). In the tuberculosis mouse model, 
transition from the exponential increase in bacterial numbers to a plateau phase occurs at 
day 21 of infection, and correlates with the accumulation of IFN-γ-producing CD4 T cells 
(Cooper and Khader, 2008; Khader et al., 2007). The critical role of CD4 T cells and IFN-γ 
in the control of mycobacterial infections has been demonstrated in different animal models 
as well as in humans, particularly in those with acquired immunodeficiencies affecting CD4 
T-cell immunity, such as HIV infection, which is one of the most important risk factors for 
development of active tuberculosis (Geldmacher et al., 2012). Therefore, understanding the 
mechanisms that govern T-cell migration and accumulation within the infected tissue are 
important.
After priming, T cells exit the draining lymph nodes, enter into the peripheral blood cir-
culation, and migrate to the lung tissue. Although the mechanisms that orchestrate the T-cell 
egress from the blood stream into the lung tissue are not completely understood, recent 
papers have identified key chemokine receptors that are important for T-cell migration 
into the lung tissue. One of these studies used intravascular flow cytometry, as previously 
described (Anderson et al., 2014), to distinguish between M. tuberculosis-specific T cells 
that are in the lung vasculature or lung parenchyma (Sakai et al., 2014). This approach 
identified two major subsets of CD4 T cells based on their location and phenotype. The 
CD4 T-cell population found mostly associated with the lung vasculature produced the 
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highest amounts of IFN-γ and expressed killer cell lectin-like receptor subfamily G member 
1 (KLRG1), CX3CR1 and high levels of the Th1 transcription factor T-bet. On the other 
hand, the lung parenchyma was enriched with CD4 T cells that produced lower amounts 
of IFN-γ, expressed CXCR3 and intermediate levels of T-bet, but did not express KLRG1 
(Sakai et al., 2014). To determine their protective role during infection, each population was 
purified and adoptively transferred into T-cell-deficient naive mice that were subsequently 
challenged with M. tuberculosis through the aerosol route. This approach showed that the 
population better able to induce control of infection produced lower levels of IFN-γ, but was 
more capable of migrating to the lung parenchyma (Sakai et al., 2014).
In this context, the chemokine receptor CXCR5 was also shown to have an important 
role in CD4 T-cell migration (Slight et al., 2013). CXCL13 is the ligand for CXCR5 and 
during M. tuberculosis infection both CXCL13 and CXCR5 are required for the formation of 
ectopic lymphoid follicles containing B and T cells (Khader et al., 2011; Slight et al., 2013). 
These follicles have also been identified in tuberculosis patients (Ulrichs et al., 2004) and 
their absence has been associated with uncontrolled disease (Ulrichs et al., 2005). In mice, 
CXCR5 expression is required to control M. tuberculosis infection (Slight et al., 2013). How-
ever, the enhanced susceptibility of CXCR5 was not associated with delayed CD4 T-cell 
priming, accumulation of CD4 T cell in the lung tissue, or altered cytokine production 
(Slight et al., 2013). Instead, T cells from CXCR5-deficient mice locate in distinct perivas-
cular cuffs, a phenotype also observed in wild-type mice that received CXCL13 (the ligand 
for CXCR5) neutralizing antibody (Slight et al., 2013).
Together, these data suggest that the coordinated expression of CXCR3 and CXCR5 is 
critical for M. tuberculosis-specific cells to migrate to the lung parenchyma and into the M. 
tuberculosis lesion where they interact with infected macrophages. Nevertheless, whether 
these receptors mediate the extravasation across the lung blood vessel into the lung paren-
chyma or the migration within the parenchyma into the lesion is yet to be determined.
The mechanism underlying the accumulation of T-cell phenotypes associated with the 
lung vasculature or parenchyma is still not well understood. While we cannot exclude the 
possibility that these phenotypes are imprinted during priming, recent data suggest that 
the lung inflammatory environment generated during infection plays a role. In this regard, 
it has been previously shown that mice deficient in IL-27 signalling are more resistant to 
M. tuberculosis (Holscher et al., 2005; Pearl et al., 2004). More recently, we have found that 
the enhanced resistance of IL-27R-deficient mice is replicated in mice deficient in IL-27R 
only in the T-cell compartment (Torrado et al., 2015). Therefore, we asked whether T cells 
differentiated differently in the absence or presence of IL-27-mediated signalling. Our data 
show that in IL-27R deficient mice, CD4 T cells were enriched in the lung parenchyma 
migratory populations, displaying reduced T-bet expression, CXCR3 and produced more 
IL-2 when compared to wild-type mice (Torrado et al., 2015). Importantly, in competitive 
bone-marrow chimeras IL-27R-deficient CD4 T cells were more fit to survive within the 
lung lesion site, when compared to wild-type CD4 T cells (Torrado et al., 2015).
Another important modulator of the T-cell response is nitric oxide produced by IFN-
γ-activated macrophages in the lesion site (Cooper et al., 2002). To test the hypothesis 
that the more activated cells within the lesion site were more sensitive to the inflammatory 
environment we resorted to the M. avium model wherein iNOS is not required to control 
infection and, indeed, it appears to benefit the host (Gomes et al., 1999). Using this model, 
we also found an increased accumulation of CD4 T cells expressing high levels of T-bet in 
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iNOS deficient when compared to wild-type mice (Pearl et al., 2012). Importantly, within 
the T-bet-expressing effector population, CD4 T cells expressing low levels of the early 
activation marker CD69 accumulate during chronic infection in higher numbers in iNOS 
deficient mice when compared to wild-type mice (Pearl et al., 2012). These data suggest that 
the terminally differentiated population (based on the expression of high T-bet and reduced 
CD69) displays an enhanced sensitivity to the regulatory effects of nitric oxide (Pearl et al., 
2012). Therefore, while nitric oxide in the phagosome may restrain intracellular bacterial 
growth, it also regulates T-cell responses, preventing the accumulation of strongly activated 
and potentially pathological T cells at the site of infection (Fig. 7.1).
Since iNOS expression is required to control M. tuberculosis, the role of nitric oxide 
in this model is more difficult to address. To overcome this issue, a recent study used a 
genetically manipulated strain of M. tuberculosis that only proliferates in the presence of 
streptomycin (Mishra et al., 2013). Without the confounding effect of bacterial prolifera-
tion, this study shows that iNOS deficient mice were still highly susceptibility to disease, 
displaying increased accumulation of neutrophils (Mishra et al., 2013). This phenotype 
was associated with increased activation of the NLRP3 inflammasome, a process depend-
ent on Esx-1-induced phagosome rupture, which resulted in elevated production of IL-1β 
(Mishra et al., 2013). The protective role of nitric oxide was shown to be the inhibition of 
the inflammasome activation through protein nitrosilation (Mishra et al., 2013). It is how-
ever important to note that, in the absence of IL-1R-mediated signalling mice are acutely 
susceptible to infection (Mayer-Barber et al., 2010). As for the IFN-α/β discussed above, 
these data show that an adequate level of IL-1 is required to control infection but in excess, 
IL-1 causes important immunopathological consequences to the host.
Together, these data suggest that the protective capacity of CD4 T cells is defined by their 
ability to rapidly migrate to the lung parenchyma and interact with infected macrophages, 
rather than by producing high levels of IFN-γ. The protective function of IFN-γ is mediated 
by activating macrophages to control intracellular growth but also by restraining immuno-
pathological responses (Nandi and Behar, 2011). The inflammatory environment generated 
in the lesion site also regulates T-cell responses. More research is required to discriminate 
between the pathological and protective inflammatory mediators and their impact in the 
control of infection.
The impact of chronic infection in T-cell function and 
granuloma formation
During chronic M. tuberculosis infection in mice, effector T-cell numbers remain relatively 
stable (Moguche et al., 2015; Winslow et al., 2003), suggesting that these cells are exposed 
to chronic antigen stimulation (Moguche et al., 2015). Over the last decade, several papers 
have shown that T cells under repetitive exposure to their cognate peptide may display 
defects in their ability to proliferate and produce cytokines, a condition known as exhaus-
tion (Barber et al., 2006; Joshi et al., 2007). In tuberculosis, CD4 T-cell activation (as 
measured by production of IFN-γ) is suboptimal in the lungs of infected animals, even at the 
peak of the response (Bold et al., 2011; Egen et al., 2011). As discussed above, mycobacteria 
can promote the recruitment of permissive macrophages that express low levels of MHC-II 
(Antonelli et al., 2010; Cambier et al., 2014), but it can also interfere with the expression and 
loading of antigens in MHC-II molecules (Hmama et al., 2015). Therefore, the suboptimal 
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activation of T cells may be associated with the reduced interaction with MHC-II molecules 
within the infection site (Srivastava and Ernst, 2013). Alternatively, T cells may develop an 
exhaustion phenotype. Indeed, the proliferative capacity of antigen-specific T cells reduces 
as the infection progresses (Reiley et al., 2010), and this is a hallmark of exhausted T cells 
(Barber et al., 2006).
One of the first papers to address T-cell exhaustion in tuberculosis determined the 
expression of two well-known markers of T-cell exhaustion in viral infections ( Joshi et al., 
2007): Programmed Death 1 (PD-1) and KLRG1 (Reiley et al., 2010). This study showed 
that, although during chronic M. tuberculosis infection T cells acquired the expression of 
either PD-1 or KLRG1, these are not markers of exhaustion during tuberculosis (Reiley 
et al., 2010). Indeed, both populations produced IFN-γ and TNF-α upon restimulation, 
with the KLRG1 population producing the highest cytokine levels (Reiley et al., 2010). 
Upon adoptive transfer into M. tuberculosis infected mice, the purified PD-1-expressing 
population maintained proliferation whereas the KLRG1-expressing population did not 
proliferate and their numbers declined over time (Reiley et al., 2010). These data suggest 
that PD-1-expressing CD4 T cells represent a proliferative population, likely responsible 
for the maintenance of the antigen-specific T-cell pool throughout infection, while KLRG1-
expressing CD4 T cells represent a terminally differentiated effector population (Reiley 
et al., 2010). Recent data support these observations and show that when transferred into 
uninfected animals, PD-1-expressing CD4 T cells are better able to persist and to provide 
enhanced protection to M. tuberculosis infection when compared to terminally differentiated, 
KLRG1-expressing, CD4 T cells (Moguche et al., 2015). Importantly, the PD-1-expressing 
CD4 T-cell population was shown to reside preferentially in the lung parenchyma, exhibit 
higher capacity to produce IL-2 and a small fraction expressed the chemokine receptor 
CXCR5 (Moguche et al., 2015).
While these data show that PD-1-expressing CD4 T cells are required for protection 
against M. tuberculosis infection, mice deficient in PD-1 are extremely susceptible to infection, 
developing wasting disease associated with a massive accumulation of mycobacteria-specific 
T cells (Barber et al., 2011; Lázár-Molnár et al., 2010). On the other hand, KLRG1 deficient 
mice are more resistant to M. tuberculosis infection, associated with increased number of 
CD4 T cells (Cyktor et al., 2013). Not only does this evidence the potential pathological 
role of the T-cell response, but also reveals that the PD-1 pathway is required to restrain 
pathological T-cell responses and prevent lethal disease.
Although PD-1 by itself may not be a marker of exhaustion, T cells express multiple 
inhibitory receptors during chronic M. tuberculosis infection, including TIM3, LAG-3, and 
2B4 ( Jayaraman et al., 2016). Interestingly, T cells that coexpress TIM3 and PD1 produced 
less IFN-γ, IL-2 and TNF-α, but more IL-10 when compared with T cells expressing only 
TIM3, suggesting that T cells that coexpress multiple inhibitory receptors are more likely 
to be exhausted ( Jayaraman et al., 2016). Accordingly, TIM3 blockade resulted in increased 
frequencies of T cells producing IFN-γ, TNF-α and IL-2 and more importantly reduced 
bacterial burdens ( Jayaraman et al., 2016). These data show T-cell exhaustion does develop 
during tuberculosis, and this may be an important mechanism to maintain chronic infection.
As T cells accumulate in the infection site, the granuloma begins to acquire a more intact 
structure, with a macrophage-rich centre surrounded by T and B cells. With time, some 
granulomata can undergo remodelling and accumulate necrotic material in the centre, lead-
ing to the formation of caseum. The caseum can then undergo liquefaction resulting in the 
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fusion with an adjacent airway, a process known as cavitation, which facilitates bacterial 
dissemination (Marakalala et al., 2016; Ndlovu and Marakalala, 2016).
Classically, the granulomatous response has been associated with a protective response 
that contains infection and prevents spreading of the bacteria to other organs. The fact that 
granuloma formation associates with control of mycobacterial infections has been sup-
ported by the hypersusceptibility to M. tuberculosis infection of humans and mice under 
various immunocompromising conditions, such as TNF-α blockade therapies, deficiency 
in the myeloid differentiation primary response protein 88 (MyD88) or the IL-12/IFN-γ 
axis (Bean et al., 1999; Chakravarty et al., 2008; Cooper et al., 1993, 1997b; Flynn et al., 
1993; Fremond et al., 2004; Lawn et al., 2002). As discussed above, infections by myco-
bacteria result in complex bacteria–host interactions wherein the bacteria can subvert 
phagocyte function. Therefore, it is possible that the hypersusceptibility to mycobacterial 
infections in immunodeficient individuals is a combination of a decreased microbicidal 
capacity of the infected macrophage and poorly formed granulomata. Furthermore, 
the role of granulomata in preventing spread of the disease to peripheral organs is also 
questionable. As discussed in the sections above, most of the M. tuberculosis modulatory 
functions are associated with the lung environment and we cannot exclude the possibility 
that the protective response in peripheral organs is more efficient in controlling bacterial 
growth, than it is in the lung. In support of this hypothesis is the fact that control of M. 
tuberculosis infection is more efficient after intravenous challenge than after aerosol chal-
lenge (Cooper, 2009; Cooper et al., 1997a). Therefore, whether granulomata formation is 
host-protective or represents an evolutionary adaption wherein the bacteria promote the 
formation of these immunological structures to spread to new host is an area of intense 
research. In fact, these issues were the subject of a recent review (Ndlovu and Marakalala, 
2016).
Whether the benefit of granulomata to the host is questionable, granuloma formation is 
likely critical for M. tuberculosis to spread to new hosts. Caseation followed by liquefaction 
of the granuloma can lead to rupture of the lesion and the release of infectious material into 
the airways. This material can then be aerosolized in cough droplets, thus facilitating bacte-
rial transmission to new hosts (Cardona, 2011). However, not all granulomata evolve into 
caseating lesions. Indeed, these lesions can be highly heterogeneous in a single host, despite 
the fact that they are likely founded by a single bacterium (Lin et al., 2014). Importantly, a 
substantial number of granulomata in animals with active disease and latent infection can 
become sterile after the onset of adaptive immunity (Lin et al., 2014). Therefore, the local 
microenvironment of each granuloma determines control or progression of infection.
Despite heterogeneity in granulomata from a single host, a recent study used laser-
capture microdissection, mass spectrometry, and confocal microscopy in human intact, 
caseous, and cavitary granulomata samples to design molecular maps of different regions 
of each granuloma type (Marakalala et al., 2016). This study identified more alterations in 
protein and lipid signatures associated with different regions of the granuloma than between 
different granulomata (Marakalala et al., 2016). Interestingly, the centres of caseous and cav-
itary granulomata (presumably more advanced lesions) were enriched in pro-inflammatory 
pathways with the presence of antimicrobial peptides, reactive oxygen species and pro-
inflammatory eicosanoids (Marakalala et al., 2016). In contrast, the most exterior tissue 
surrounding the granuloma displayed an anti-inflammatory signature (Marakalala et al., 
2016).
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The impact of this structural organization of the granuloma in the T-cell response, and 
vice versa, is not yet determined. Future work will be critical to determine whether the anti-
inflammatory rim of the granuloma is an evolutionary adaption of host to prevent further 
immunopathological consequences or an intricate strategy of the pathogen to prevent the 
entrance of antigen-specific T cells or modulate their phenotype and function. Whatever 
the answer, understanding how T cells accumulate and organize within these structures will 
be critical to define T cell correlates of protection. As granulomata are essential for M. tuber-
culosis to spread to new hosts, T cells are also essential for the success of M. tuberculosis as a 
human pathogen. Indeed, M. tuberculosis epitopes recognized by T cells are evolutionarily 
conserved (Comas et al., 2010; Coscolla et al., 2015), suggesting that M. tuberculosis benefits 
from T-cell recognition.
Taken together with the data discussed above, pro-inflammatory eicosanoids appear 
to play a key role in the T-cell response but also in the progression of the granulomatous 
response. During the early stages of infection pro-inflammatory eicosanoids induce necrotic 
cell death of infected-macrophages, thus delaying T-cell responses and promoting phagocy-
tosis of the bacteria by newly recruited macrophages. After the onset of acquired responses, 
these macrophages are likely defective in interacting with T cells and more permissive to 
intracellular growth. As these cells die, a necrotic centre begins to form promoting its fusion 
with the airways, facilitating transmission of infection (Fig. 7.1).
Mycobacterium ulcerans infection: an extreme among 
mycobacteria
Although M. ulcerans and M. tuberculosis display a high degree of genetic similarity (Deman-
gel et al., 2009), the phenotypic clinical manifestations associated to infection with these 
mycobacteria differ greatly. This is, at least in part, due to the fact that M. ulcerans produces 
mycolactone, a dermonecrotic exotoxin that is responsible for the extensive destruction of 
the subcutaneous tissue and adjacent epidermis observed in Buruli ulcer patients (George et 
al., 1999). Although early clinical manifestations of Buruli ulcer include the non-ulcerative 
nodules, plaques and oedemas, due to the indolent nature of the lesions, there is often a 
delay in health-care seeking, which allows non-ulcerative manifestations to progress to more 
severe ulcerative forms (Walsh et al., 2008).
Mycolactone is a small hydrophobic macrolide produced by a group of polyketide 
synthases and polyketide-modifying enzymes, encoded by a giant virulence plasmid 
pMUM001 (Stinear et al., 2004). This toxin has been shown to passively diffuse through the 
cell membrane (Snyder and Small, 2003) rather than via a transporter-mediated mechanism 
and concentrates in the cytoplasm (Snyder and Small, 2003).
Despite the unique ability of M. ulcerans to secrete a toxin, the mycobacterial nature of 
M. ulcerans plays an important role in the development of a cell mediated immune response. 
Like other pathogenic mycobacteria, M. ulcerans is an intracellular pathogen that elicits a 
persistent recruitment of inflammatory cells to the site of infection, namely neutrophils and 
macrophages (Oliveira et al., 2005). Initial recognition of M. ulcerans appears to be mediated 
through TLR-2, TLR-4 and Dectin-1 that actively participate in the sensing and internaliza-
tion of the pathogen (Lee et al., 2009), contributing to an antimycobacterial response with 
the release of reactive oxygen species (Lee et al., 2009), reactive nitrogen species (Torrado et 
al., 2010) and inflammatory cytokines and chemokines (Torrado et al., 2007). However, the 
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bacterial proliferation associated to the progressively increasing concentrations of mycolac-
tone at the site of infection, eventually starts to hamper the potentially protective immune 
response mounted by the host.
Among the deleterious effects of mycolactone, the toxin has been associated to structural 
alterations of actin- and tubulin-cytoskeleton, that disturbs the cell shape as well as mul-
tiple cytoskeleton-dependent cellular functions. In fact, mycolactone-induced cytoskeletal 
alterations can be mediated through the hyperactivation of the actin-cytoskeleton regula-
tor Wiskott-Aldrich syndrome protein (WASP) (Guenin-Macé et al., 2013), a nucleation 
promoting factor that activates the Arp2/3 complex in order to stimulate nucleation of 
branched actin filaments (Burianek and Soderling, 2013). By hijacking and disrupting 
WASP autoinhibition, mycolactone leads to uncontrolled activation of WASP and results 
in defective cell adhesion and migration due to the accumulation of small, highly branched 
actin filaments, rather than long microfilaments (Guenin-Macé et al., 2013). Mycolactone 
also affects cytoskeleton-dependent functions with important consequences for cellular 
homeostasis. A recent proteomic study revealed several regulators and structural constitu-
ents of the cytoskeleton that are affected upon exposure to mycolactone (Gama et al., 2014). 
For example, the cytoplasmic dynein 1 intermediate chain 2 (Dync1i2), a non-catalytic 
subunit of the microtubule-associated molecular motor dynein, that was shown to be 
down-regulated in mycolactone-treated cells (Gama et al., 2014). Several cellular processes 
dependent on cytoskeleton architecture and dynein-driven transport have been reported 
to be affected by mycolactone. Specifically, the toxin can affect the transport of vesicles and 
organelles throughout the cytoskeleton tracks, allowing the pathogen to subvert innate 
microbicidal defences. Indeed, increasing concentrations of mycolactone impair phago-
some–lysosome fusion in IFN-γ activated macrophages, which results in a deficient control 
in bacterial proliferation (Torrado et al., 2010), as well an accumulation of autophagosomes, 
given their inability to fuse with lysosomes (Gama et al., 2014).
Mycolactone does not act only upon the cytoskeleton. Another well-known effect of 
mycolactone is the down-regulation of specific proteins implicated in host immunity, such 
as cytokines and chemokines (Baron et al., 2016; Hall et al., 2014; Simmonds et al., 2009; 
Torrado et al., 2007). Interestingly, however, the reduced cytokine production during M. 
ulcerans infection does not appear to result from decreased gene transcription or even pro-
tein translation, but rather a blockage in the process of protein export (Hall et al., 2014; 
Simmonds et al., 2009). Indeed, mycolactone has been shown to directly target the α subu-
nit of the Sec61 translocon (Baron et al., 2016) and inhibit the cotranslational translocation 
of nascent proteins into the endoplasmatic reticulum due to a conformational change in the 
Sec61 translocation complex, to a stabilized closed conformation (Hall et al., 2014; McK-
enna et al., 2016). The mycolactone-dependent blockade of Sec61 translocation ultimately 
results in the accumulation and degradation of newly synthesized ER-transiting proteins in 
the cytoplasm (Hall et al., 2014; Simmonds et al., 2009). Accordingly, it was recently shown 
that there is an excessive accumulation of ubiquitnated proteins in fibroblasts treated with 
mycolactone (Gama et al., 2014).
Despite the impact of mycolactone on the innate response, an acquired immune response 
is mounted, with the accumulation and proliferation of antigen-specific T cells in the drain-
ing lymph node (Fraga et al., 2011). However, similar to what is observed in M. tuberculosis 
infection, there is a delay in the generation of acquired immunity, taking up to day 7 post 
infection to develop a specific T-cell response. This delay has been attributed, at least in part, 
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to the ability of mycolactone to inhibit the maturation and migration of DCs to the draining 
lymph node (Coutanceau et al., 2007). This delay allows exponential bacterial proliferation 
with the further build-up of mycolactone in the infected tissue, amplifying its deleterious 
effects. For example, the toxin has been shown to have a direct effect on T-cell responsive-
ness to stimulation by affecting the expression of the T-cell homing receptor CD62L, thus 
impairing their capacity to reach peripheral lymph nodes and respond to chemotactic signals 
(Guenin-Macé et al., 2011). Moreover, mycolactone also induces the hyperactivation of the 
Src-family kinase, Lck, which results in a deregulation of intracellular signalling pathways 
involve in T-cell receptor activation (Boulkroun et al., 2010). Ultimately, the uncontrolled 
proliferation of M. ulcerans leads to the complete destruction of the draining lymph node 
(Fraga et al., 2011), either due to bacterial colonization as a result of dissemination of M. 
ulcerans via afferent lymphatic drainage or due to diffusion of mycolactone from the site of 
infection.
The end result of the effect of mycolactone is cell death. While M. tuberculosis can clearly 
manipulate the fate of the infected cell and determine the modality of cell death to its own 
advantage, M. ulcerans takes this trait to a whole new level. Indeed, the first identified function 
of mycolactone was the induction of cell death. It has been shown that mycolactone-treated 
cells present an arrest in the G0/G1-phase as early as 48 hours post incubation (Gama et 
al., 2014; George et al., 1999). Longer periods of incubation lead to an accumulation of the 
sub-G0/G1 population, compatible with apoptotic cells (Gama et al., 2014; George et al., 
1999). Interestingly, the arrest of the G1 cell cycle progression has been shown to occur after 
drug-induced inhibition of actin assembly (Bohmer et al., 1996; Huang et al., 1998; Iwig 
et al., 1995; Maness and Walsh, 1982; Reshetnikova et al., 2000), further implicating the 
cytoskeleton in the mycolactone-mediated cytopathic effect. Additional evidence for the 
role of mycolactone as an apoptotic inducer are in vivo reports describing the presence of 
apoptotic cells in human Buruli ulcer lesions (Walsh et al., 2005) and in infected lesions of 
experimental animal models (George et al., 1999, 2000; Oliveira et al., 2005; Silva-Gomes et 
al., 2015). However, the continuous build-up of mycolactone during progressive M. ulcerans 
infection results in an overwhelming accumulation of apoptotic cells in the infected tissue. 
The inability of scavenger phagocytic cells to efficiently clear the tissue of these apoptotic 
cells eventually leads to secondary necrosis followed by autolysis. This post-apoptotic sec-
ondary necrosis is behind the progressively expanding necrotic areas observed in Buruli 
ulcer lesions (Silva et al., 2009).
Despite the size of these necrotic lesions, with some exceeding 15 cm in diameter, 
Buruli ulcer is an indolent disease. Mycolactone is described to have an analgesic effect to 
annul the pain caused during M. ulcerans infection (Marion et al., 2014). Hypoesthesia is 
achieved through the binding of mycolactone to type 2 angiotensin II receptors (AT2R), 
which triggers phospholipase A2 (PLA2) activation and arachidonic acid release (Marion 
et al., 2014). Arachidonic acid is then metabolized by COX-1 into PGE2, leading to the 
activation of TRAAK channels and a consequent potassium-dependent hyperpolarization 
of neurons (Marion et al., 2014). This strategy seems to provide an evolutionary advantage 
for M. ulcerans, in which the lack of pain could possibly allow an uncontrolled expansion of 
necrotic areas with numerous extracellular bacilli and the potential shedding of bacteria to 
the environment, perpetuating its infectious cycle.
Collectively, these data show that, like other mycobacteria, M. ulcerans is an intracellular 
pathogen and induces T-cell responses which are required to control infection. However, 
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the pathophysiology of Buruli ulcer is dominated by the effect of mycolactone, which makes 
M. ulcerans unique within the genus.
Conclusion
The outcome of mycobacterial infections is dependent on the complex interaction between 
the intracellular pathogen and the immune system. Through this interaction, mycobacteria 
have evolved to adapt to its host by developing intricate mechanisms to subvert the immune 
response. However, the immune response may also contribute decisively for the success 
of mycobacteria as human pathogens. In this regard, M. tuberculosis has developed several 
mechanisms to modulate the activation and the effector function of the phagocytic cell, 
likely to prevent its rapid elimination rather than to completely shut down the immune 
system. The initial manipulation of the phagocyte response then allows the bacteria to sur-
vive within the host cell, while an antigen-specific immune response is still being mounted. 
This response eventually culminates in the formation of an inflammatory granulomatous 
structure that prevents the spreading of the bacteria to peripheral organs. However, its for-
mation and breakdown has also proven to be essential for the bacteria to spread to new hosts. 
Understanding this duality will be important for the development of host-specific therapies. 
As an extreme example of mycobacterial survival, the immune evasion mechanisms used by 
M. ulcerans mainly depend on the actions of the necrotizing toxin mycolactone.
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